Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Opioid that also blocks noradrenaline reuptake. | Moderate opioid with antidepressant-like actions. |
| Body system | Pain & Fever | Pain & Fever |
| Drug class | Opioids | Opioids |
| Supply | Controlled drug | Controlled drug |
| Main uses | Moderate to severe acute pain, Chronic severe pain, Painful diabetic neuropathy (extended-release) | Moderate to severe pain, Pain after surgery, Osteoarthritis pain (short term) |
| How it works | Strong painkiller with a second action on nerve signalling. | Acts on opioid receptors and on the brain's pain-dampening chemicals. |
| Starts working | 30–60 minutes | About 1 hour |
| Half-life | About 4 hours | About 6 hours |
| Typical adult dose | 50–100 mg every 4–6 hours (immediate-release); extended-release 50–250 mg twice a day. | 50–100 mg every 4–6 hours, maximum 400 mg a day (lower in older adults and kidney disease). |
| Forms | Tablet, Extended-release tablet | Capsule, Tablet, Modified-release tablet, Injection, Orodispersible tablet |
| Common side effects | Nausea, Dizziness, Constipation, Drowsiness, Headache | Nausea, Dizziness, Constipation, Sweating, Drowsiness, Headache |
| Serious side effects | Slow breathing, Seizures, Serotonin syndrome, Dependence | Seizures, Serotonin syndrome, Slowed breathing, Dependence, Low blood sugar |
| Don't take if | Taking MAOIs (or within 2 weeks); Severe asthma; Paralytic ileus; Uncontrolled epilepsy | Uncontrolled epilepsy or a history of seizures; Taking an MAOI or within 14 days of stopping one; Severe breathing problems; Under 12 years of age |
| Alcohol | Best avoided. Alcohol adds to dangerous drowsiness and breathing depression. | Best avoided. Alcohol adds to drowsiness and breathing depression and can raise seizure risk. |
| Pregnancy | Usually avoidedAvoid in pregnancy unless essential. | Use with cautionAvoid unless clearly needed; withdrawal can occur in the newborn. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedPasses into milk; can sedate the baby. Avoid. |
| In use since | — | 1977 |
| Brand names | United States: NucyntaUnited Kingdom: PalexiaIndia: Tapal, Nucynta | United States: Ultram, Ultracet (with paracetamol)United Kingdom: Zydol, Tramacet (with paracetamol)India: Contramal, Ultracet |
| Legal status | United States: Controlled substance (Schedule II)United Kingdom: Controlled drug (Schedule 2)India: Schedule H1 (NDPS scheduling recommended in 2025; no notification found) | United States: Controlled substance (Schedule IV)United Kingdom: Controlled drug (Schedule 3)India: Schedule H1 (sales are recorded) |
| ATC code | N02AX06 | N02AX02 |
Taken together
- MajorTapentadol + Tramadol: Dangerous drowsiness and slowed breathing
Opioids combined with other opioids, benzodiazepines, gabapentinoids, sleeping tablets or sedating medicines can stop breathing. Many fatal overdoses involve such combinations.
- ModerateTapentadol + Tramadol: Serotonin syndrome risk
Both medicines raise serotonin. Most combinations are tolerated, but the risk of serotonin toxicity rises, particularly when starting or increasing doses.
- ModerateTapentadol + Tramadol: Increased seizure risk
Both medicines lower the seizure threshold.
- ModerateTapentadol + Tramadol: Serotonin toxicity
Some opioids, especially tramadol and fentanyl, add serotonergic activity to antidepressants and other serotonin-raising medicines.